Gene Panel Market Research Report Information By Technique (Amplicon Based Approach and Hybridization Based Approach) By Design (Predesigned Gene Panel and Customized Gene Panel) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

1 EXECUTIVE SUMMARY

1.1 OVERVIEW 18

1.1.1 MARKET SYPNOSIS 18

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY 19

2.2 RESEARCH OBJECTIVE 19

2.3 LIST OF ASSUMPTIONS 20

3 RESEARCH METHODOLOGY

3.1 OVERVIEW 22

3.2 DATA MINING 22

3.3 SECONDARY RESEARCH 23

3.4 PRIMARY RESEARCH 24

3.5 FORECASTING METHODS 25

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 26

3.6.1 BOTTOM-UP APPROACH 27

3.6.2 TOP-DOWN APPROACH 27

3.7 DATA TRIANGULATION 28

3.8 VALIDATION 28

4 MARKET DYNAMICS

4.1 OVERVIEW 29

4.2 DRIVERS 30

4.2.1 INCREASING PREVALENCE OF CANCER 30

4.2.2 BENEFITS OF GENE PANELS 30

4.3 RESTRAINTS 32

4.3.1 LIMITATIONS IN GENE PANEL TESTING AND INACCURACY OF TEST 32

4.4 OPPORTUNITIES 32

4.4.1 GROWTH POTENTIAL IN EMERGING COUNTRIES 32

4.5 CHALLENGES 33

5 MARKET FACTOR ANALYSIS

5.1 PORTER’S FIVE FORCES MODEL 34

5.1.1 BARGAINING POWER OF SUPPLIERS 34

5.1.2 BARGAINING POWER OF BUYERS 35

5.1.3 THREAT OF NEW ENTRANTS 35

5.1.4 THREAT OF SUBSTITUTES 35

5.1.5 INTENSITY OF RIVALRY 35

5.2 VALUE CHAIN ANALYSIS 36

5.2.1 R&D 37

5.2.2 MANUFACTURING 37

5.2.3 DISTRIBUTION 37

5.2.4 MARKETING & SALES 37

5.3 INVESTMENT SCENARIO 37

5.3.1 INVESTMENT RISKS 38

5.3.2 MARKET OUTLOOK 38

5.3.3 COMPETITORS 38

5.3.4 PROJECTIONS 38

5.4 PRICING ANALYSIS 38

6 GENE PANEL MARKET, BY PRODUCT & SERVICE

6.1 OVERVIEW 39

6.2 TEST KITS 40

6.3 TESTING SERVICES 40

7 GENE PANEL MARKET, BY TECHNIQUE

7.1 OVERVIEW 42

7.2 AMPLICON-BASED APPROACH 43

7.3 HYBRIDIZATION-BASED APPROACH 44

8 GENE PANEL MARKET, BY DESIGN

8.1 OVERVIEW 45

8.2 PREDESIGNED GENE PANELS 46

8.3 CUSTOMIZED GENE PANELS 46

9 GENE PANEL MARKET, BY APPLICATION

9.1 OVERVIEW 48

9.2 CANCER RISK ASSESSMENT 50

9.3 DIAGNOSIS 51

9.4 PHARMACOGENETICS 51

10 GENE PANEL MARKET, BY END USER

10.1 OVERVIEW 52

10.2 HOSPITALS 53

10.3 DIAGNOSTIC LABORATORIES 54

11 GLOBAL GENE PANEL MARKET, BY REGION

11.1 OVERVIEW 55

11.2 AMERICAS 57

GENE PANEL MARKET, BY PRODUCT & SERVICE

GENE PANEL MARKET, BY TECHNIQUE

GENE PANEL MARKET, BY DESIGN

GENE PANEL MARKET, BY APPLICATION

GENE PANEL MARKET, BY END USER

11.2.1 NORTH AMERICA 60

GENE PANEL MARKET, BY PRODUCT & SERVICE

GENE PANEL MARKET, BY TECHNIQUE

GENE PANEL MARKET, BY DESIGN

GENE PANEL MARKET, BY APPLICATION

GENE PANEL MARKET, BY END USER

11.2.1.1 US 63

GENE PANEL MARKET, BY PRODUCT & SERVICE

GENE PANEL MARKET, BY TECHNIQUE

GENE PANEL MARKET, BY DESIGN

GENE PANEL MARKET, BY APPLICATION

GENE PANEL MARKET, BY END USER

11.2.1.2 CANADA 66

GENE PANEL MARKET, BY PRODUCT & SERVICE

GENE PANEL MARKET, BY TECHNIQUE

GENE PANEL MARKET, BY DESIGN

GENE PANEL MARKET, BY APPLICATION

GENE PANEL MARKET, BY END USER

11.2.2 LATIN AMERICA 68

GENE PANEL MARKET, BY PRODUCT & SERVICE

GENE PANEL MARKET, BY TECHNIQUE

GENE PANEL MARKET, BY DESIGN

GENE PANEL MARKET, BY APPLICATION

GENE PANEL MARKET, BY END USER

11.3 EUROPE 72

GENE PANEL MARKET, BY PRODUCT & SERVICE

GENE PANEL MARKET, BY TECHNIQUE

GENE PANEL MARKET, BY DESIGN

GENE PANEL MARKET, BY APPLICATION

GENE PANEL MARKET, BY END USER

11.3.1 WESTERN EUROPE 75

GENE PANEL MARKET, BY PRODUCT & SERVICE

GENE PANEL MARKET, BY TECHNIQUE

GENE PANEL MARKET, BY DESIGN

GENE PANEL MARKET, BY APPLICATION

GENE PANEL MARKET, BY END USER

11.3.1.1 GERMANY 78

GENE PANEL MARKET, BY PRODUCT & SERVICE

GENE PANEL MARKET, BY TECHNIQUE

GENE PANEL MARKET, BY DESIGN

GENE PANEL MARKET, BY APPLICATION

GENE PANEL MARKET, BY END USER

11.3.1.2 UK 81

GENE PANEL MARKET, BY PRODUCT & SERVICE

GENE PANEL MARKET, BY TECHNIQUE

GENE PANEL MARKET, BY DESIGN

GENE PANEL MARKET, BY APPLICATION

GENE PANEL MARKET, BY END USER

11.3.1.3 FRANCE 83

GENE PANEL MARKET, BY PRODUCT & SERVICE

GENE PANEL MARKET, BY TECHNIQUE

GENE PANEL MARKET, BY DESIGN

GENE PANEL MARKET, BY APPLICATION

GENE PANEL MARKET, BY END USER

11.3.1.4 ITALY 86

GENE PANEL MARKET, BY PRODUCT & SERVICE

GENE PANEL MARKET, BY TECHNIQUE

GENE PANEL MARKET, BY DESIGN

GENE PANEL MARKET, BY APPLICATION

GENE PANEL MARKET, BY END USER

11.3.1.5 SPAIN 88

GENE PANEL MARKET, BY PRODUCT & SERVICE

GENE PANEL MARKET, BY TECHNIQUE

GENE PANEL MARKET, BY DESIGN

GENE PANEL MARKET, BY APPLICATION

GENE PANEL MARKET, BY END USER

11.3.1.6 REST OF WESTERN EUROPE 91

GENE PANEL MARKET, BY PRODUCT & SERVICE

GENE PANEL MARKET, BY TECHNIQUE

GENE PANEL MARKET, BY DESIGN

GENE PANEL MARKET, BY APPLICATION

GENE PANEL MARKET, BY END USER

11.3.2 EASTERN EUROPE 93

GENE PANEL MARKET, BY PRODUCT & SERVICE

GENE PANEL MARKET, BY TECHNIQUE

GENE PANEL MARKET, BY DESIGN

GENE PANEL MARKET, BY APPLICATION

GENE PANEL MARKET, BY END USER

11.4 ASIA-PACIFIC 97

GENE PANEL MARKET, BY PRODUCT & SERVICE

GENE PANEL MARKET, BY TECHNIQUE

GENE PANEL MARKET, BY DESIGN

GENE PANEL MARKET, BY APPLICATION

GENE PANEL MARKET, BY END USER

11.4.1 JAPAN 100

GENE PANEL MARKET, BY PRODUCT & SERVICE

GENE PANEL MARKET, BY TECHNIQUE

GENE PANEL MARKET, BY DESIGN

GENE PANEL MARKET, BY APPLICATION

GENE PANEL MARKET, BY END USER

11.4.2 CHINA 103

GENE PANEL MARKET, BY PRODUCT & SERVICE

GENE PANEL MARKET, BY TECHNIQUE

GENE PANEL MARKET, BY DESIGN

GENE PANEL MARKET, BY APPLICATION

GENE PANEL MARKET, BY END USER

11.4.3 INDIA 105

GENE PANEL MARKET, BY PRODUCT & SERVICE

GENE PANEL MARKET, BY TECHNIQUE

GENE PANEL MARKET, BY DESIGN

GENE PANEL MARKET, BY APPLICATION

GENE PANEL MARKET, BY END USER

11.4.4 AUSTRALIA 108

GENE PANEL MARKET, BY PRODUCT & SERVICE

GENE PANEL MARKET, BY TECHNIQUE

GENE PANEL MARKET, BY DESIGN

GENE PANEL MARKET, BY APPLICATION

GENE PANEL MARKET, BY END USER

11.4.5 SOUTH KOREA 111

GENE PANEL MARKET, BY PRODUCT & SERVICE

GENE PANEL MARKET, BY TECHNIQUE

GENE PANEL MARKET, BY DESIGN

GENE PANEL MARKET, BY APPLICATION

GENE PANEL MARKET, BY END USER

11.4.6 REST OF ASIA-PACIFIC 113

GENE PANEL MARKET, BY PRODUCT & SERVICE

GENE PANEL MARKET, BY TECHNIQUE

GENE PANEL MARKET, BY DESIGN

GENE PANEL MARKET, BY APPLICATION

GENE PANEL MARKET, BY END USER

11.5 MIDDLE EAST & AFRICA 117

GENE PANEL MARKET, BY PRODUCT & SERVICE

GENE PANEL MARKET, BY TECHNIQUE

GENE PANEL MARKET, BY DESIGN

GENE PANEL MARKET, BY APPLICATION

GENE PANEL MARKET, BY END USER

11.5.1 UNITED ARAB EMIRATES 120

GENE PANEL MARKET, BY PRODUCT & SERVICE

GENE PANEL MARKET, BY TECHNIQUE

GENE PANEL MARKET, BY DESIGN

GENE PANEL MARKET, BY APPLICATION

GENE PANEL MARKET, BY END USER

11.5.2 SAUDI ARABIA 123

GENE PANEL MARKET, BY PRODUCT & SERVICE

GENE PANEL MARKET, BY TECHNIQUE

GENE PANEL MARKET, BY DESIGN

GENE PANEL MARKET, BY APPLICATION

GENE PANEL MARKET, BY END USER

11.5.3 REST OF MIDDLE EAST & AFRICA 125

GENE PANEL MARKET, BY PRODUCT & SERVICE

GENE PANEL MARKET, BY TECHNIQUE

GENE PANEL MARKET, BY DESIGN

GENE PANEL MARKET, BY APPLICATION

GENE PANEL MARKET, BY END USER

12 COMPETITIVE LANDSCAPE

12.1 OVERVIEW 129

12.2 COMPANY RANKING ANALYSIS 129

12.3 KEY DEVELOPMENT ANALYSIS 130

13 COMPANY PROFILES

13.1 AGILENT TECHNOLOGIES, INC. 131

13.1.1 COMPANY OVERVIEW 131

13.1.2 FINANCIAL OVERVIEW 132

13.1.3 PRODUCTS/SERVICES OFFERED 132

13.1.4 KEY DEVELOPMENTS 133

13.1.5 SWOT ANALYSIS 133

13.1.6 KEY STRATEGIES 133

13.2 THERMO FISHER SCIENTIFIC 134

13.2.1 COMPANY OVERVIEW 134

13.2.2 FINANCIAL OVERVIEW 134

13.2.3 PRODUCTS/SERVICES OFFERED 135

13.2.4 KEY DEVELOPMENTS 135

13.2.5 SWOT ANALYSIS 136

13.2.6 KEY STRATEGIES 136

13.3 F. HOFFMANN-LA ROCHE LTD 137

13.3.1 COMPANY OVERVIEW 137

13.3.2 FINANCIAL OVERVIEW 137

13.3.3 PRODUCTS/SERVICES OFFERED 138

13.3.4 KEY DEVELOPMENTS 138

13.3.5 SWOT ANALYSIS 138

13.3.6 KEY STRATEGIES 139

13.4 QIAGEN 140

13.4.1 COMPANY OVERVIEW 140

13.4.2 FINANCIAL OVERVIEW 140

13.4.3 PRODUCTS/SERVICES OFFERED 141

13.4.4 KEY DEVELOPMENTS 141

13.4.5 SWOT ANALYSIS 142

13.4.6 KEY STRATEGIES 142

13.5 ILLUMINA INC. 143

13.5.1 COMPANY OVERVIEW 143

13.5.2 FINANCIAL OVERVIEW 143

13.5.3 PRODUCTS/SERVICES OFFERED 144

13.5.4 KEY DEVELOPMENTS 144

13.5.5 SWOT ANALYSIS 145

13.5.6 KEY STRATEGIES 145

13.6 BGI 146

13.6.1 COMPANY OVERVIEW 146

13.6.2 FINANCIAL OVERVIEW 146

13.6.3 PRODUCTS/SERVICES OFFERED 147

13.6.4 KEY DEVELOPMENTS 147

13.6.5 SWOT ANALYSIS 147

13.6.6 KEY STRATEGIES 148

13.7 INTEGRATED DNA TECHNOLOGIES, INC. 149

13.7.1 COMPANY OVERVIEW 149

13.7.2 FINANCIAL OVERVIEW 150

13.7.3 PRODUCTS/SERVICES OFFERED 150

13.7.4 KEY DEVELOPMENTS 151

13.7.5 SWOT ANALYSIS 151

13.7.6 KEY STRATEGIES 151

13.8 GENEWIZ 152

13.8.1 COMPANY OVERVIEW 152

13.8.2 FINANCIAL OVERVIEW 153

13.8.3 PRODUCTS/SERVICES OFFERED 153

13.8.4 KEY DEVELOPMENTS 154

13.8.5 SWOT ANALYSIS 154

13.8.6 KEY STRATEGIES 154

13.9 NOVOGENE CORPORATION 155

13.9.1 COMPANY OVERVIEW 155

13.9.2 FINANCIAL OVERVIEW 155

13.9.3 PRODUCTS/SERVICES OFFERED 155

13.9.4 KEY DEVELOPMENTS 155

13.9.5 SWOT ANALYSIS 156

13.9.6 KEY STRATEGIES 156

13.10 PERSONALIS, INC. 157

13.10.1 COMPANY OVERVIEW 157

13.10.2 FINANCIAL OVERVIEW 158

13.10.3 YEARLY COMPARISION 158

13.10.3.1 REVENUE COMPARISON OF THE THREE MONTHS ENDED MARCH 31, 2020 AND 2019 158

13.10.3.2 RESEARCH AND DEVELOPMENT EXPENSES COMPARISON OF THE THREE MONTHS ENDED MARCH 31, 2020 AND 2019 158

13.10.3.3 SOURCES OF LIQUIDITY 159

13.10.4 MATERIAL AGREEMENTS 159

13.10.5 COMPETITION 159

13.10.6 PRODUCTS/SERVICES OFFERED 160

13.10.7 KEY DEVELOPMENTS 160

13.10.8 SWOT ANALYSIS 160

13.10.9 KEY STRATEGIES 160

13.11 GATC BIOTECH AG 161

13.11.1 COMPANY OVERVIEW 161

13.11.2 FINANCIAL OVERVIEW 161

13.11.3 BUSINESS COMBINATIONS OF EUROFINS SCIENTIFIC, 2020 163

13.11.4 PRODUCTS/SERVICES OFFERED 164

13.11.5 KEY DEVELOPMENTS 164

13.11.6 SWOT ANALYSIS 164

13.11.7 KEY STRATEGIES 164

13.12 ARCHERDX, INC 165

13.12.1 COMPANY OVERVIEW 165

13.12.2 FINANCIAL TRANSACTIONS 165

13.12.3 PRODUCTS/SERVICES OFFERED 166

13.12.4 KEY DEVELOPMENTS 166

13.12.5 SWOT ANALYSIS 167

13.12.6 KEY STRATEGIES 167

13.13 GENEDX 168

13.13.1 COMPANY OVERVIEW 168

13.13.2 FINANCIAL OVERVIEW 168

13.13.3 PRODUCTS/SERVICES OFFERED 168

13.13.4 KEY DEVELOPMENTS 169

13.13.5 SWOT ANALYSIS 169

13.13.6 KEY STRATEGIES 169

13.14 CENTOGENE AG 170

13.14.1 COMPANY OVERVIEW 170

13.14.2 FINANCIAL OVERVIEW 171

13.14.2.1 FINANCIAL OPERATIONS OVERVIEW 172

13.14.2.1.1 COST OF SALES 172

13.14.2.1.2 RESEARCH AND DEVELOPMENT EXPENSES 172

13.14.2.2 FINANCIAL OVERVIEW, BY SOLUTION 172

13.14.2.2.1 PHARMACEUTICAL 172

13.14.2.2.2 DIAGNOSTICS 172

13.14.3 PRODUCTS/SERVICES OFFERED 173

13.14.4 KEY DEVELOPMENTS 173

13.14.5 SWOT ANALYSIS 173

13.14.6 KEY STRATEGIES 173

14 APPENDIX

14.1 REFERENCES 174

14.2 RELATED REPORTS 174

15 LIST OF TABLES`

TABLE 1 LIST OF ASSUMPTIONS 20

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 24

TABLE 3 GLOBAL GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 40

TABLE 4 GLOBAL GENE PANEL MARKET FOR TEST KITS, BY REGION, 2020-2027 (USD MILLION) 40

TABLE 5 GLOBAL GENE PANEL MARKET FOR TESTING SERVICES, BY REGION, 2020-2027 (USD MILLION) 41

TABLE 6 GLOBAL GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 43

TABLE 7 GLOBAL GENE PANEL MARKET FOR AMPLICON-BASED APPROACH, BY REGION, 2020-2027 (USD MILLION) 43

TABLE 8 GLOBAL GENE PANEL MARKET FOR HYBRIDIZATION-BASED APPROACH, BY REGION, 2020-2027 (USD MILLION) 44

TABLE 9 GLOBAL GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 46

TABLE 10 GLOBAL GENE PANEL MARKET FOR PREDESIGNED GENE PANELS, BY REGION, 2020-2027 (USD MILLION) 46

TABLE 11 GLOBAL GENE PANEL MARKET FOR CUSTOMIZED GENE PANELS, BY REGION, 2020-2027 (USD MILLION) 47

TABLE 12 GLOBAL GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 49

TABLE 13 GLOBAL GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 49

TABLE 14 GLOBAL GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 49

TABLE 15 GLOBAL GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 50

TABLE 16 GLOBAL GENE PANEL MARKET FOR CANCER RISK ASSESSMENT, BY REGION, 2020-2027 (USD MILLION) 50

TABLE 17 GLOBAL GENE PANEL MARKET FOR DIAGNOSIS, BY REGION, 2020-2027 (USD MILLION) 51

TABLE 18 GLOBAL GENE PANEL MARKET FOR PHARMACOGENETICS, BY REGION, 2020-2027 (USD MILLION) 51

TABLE 19 GLOBAL GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 53

TABLE 20 GLOBAL GENE PANEL MARKET FOR HOSPITALS, BY REGION, 2020-2027 (USD MILLION) 53

TABLE 21 GLOBAL GENE PANEL MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2020-2027 (USD MILLION) 54

TABLE 22 GLOBAL GENE PANEL MARKET, BY REGION, 2020-2027 (USD MILLION) 56

TABLE 23 AMERICAS: GENE PANEL MARKET, BY REGION, 2020-2027 (USD MILLION) 57

TABLE 24 AMERICAS: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 57

TABLE 25 AMERICAS: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 58

TABLE 26 AMERICAS: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 58

TABLE 27 AMERICAS: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 58

TABLE 28 AMERICAS: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 59

TABLE 29 AMERICAS: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 59

TABLE 30 AMERICAS: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 59

TABLE 31 AMERICAS: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 60

TABLE 32 NORTH AMERICA: GENE PANEL MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 60

TABLE 33 NORTH AMERICA: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 61

TABLE 34 NORTH AMERICA: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 61

TABLE 35 NORTH AMERICA: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 61

TABLE 36 NORTH AMERICA: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 61

TABLE 37 NORTH AMERICA: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 62

TABLE 38 NORTH AMERICA: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 62

TABLE 39 NORTH AMERICA: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 62

TABLE 40 NORTH AMERICA: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 63

TABLE 41 US: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 63

TABLE 42 US: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 63

TABLE 43 US: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 64

TABLE 44 US: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 64

TABLE 45 US: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 64

TABLE 46 US: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 65

TABLE 47 US: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 65

TABLE 48 US: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 65

TABLE 49 CANADA: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 66

TABLE 50 CANADA: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 66

TABLE 51 CANADA: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 66

TABLE 52 CANADA: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 67

TABLE 53 CANADA: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 67

TABLE 54 CANADA: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 67

TABLE 55 CANADA: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 68

TABLE 56 CANADA: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 68

TABLE 57 LATIN AMERICA: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 68

TABLE 58 LATIN AMERICA: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 69

TABLE 59 LATIN AMERICA: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 69

TABLE 60 LATIN AMERICA: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 69

TABLE 61 LATIN AMERICA: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 70

TABLE 62 LATIN AMERICA: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 70

TABLE 63 LATIN AMERICA: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 70

TABLE 64 LATIN AMERICA: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 71

TABLE 65 EUROPE: GENE PANEL MARKET, BY REGION, 2020-2027 (USD MILLION) 72

TABLE 66 EUROPE: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 72

TABLE 67 EUROPE: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 73

TABLE 68 EUROPE: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 73

TABLE 69 EUROPE: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 73

TABLE 70 EUROPE: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 73

TABLE 71 EUROPE: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 74

TABLE 72 EUROPE: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 74

TABLE 73 EUROPE: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 74

TABLE 74 WESTERN EUROPE: GENE PANEL MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 75

TABLE 75 WESTERN EUROPE: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 75

TABLE 76 WESTERN EUROPE: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 76

TABLE 77 WESTERN EUROPE: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 76

TABLE 78 WESTERN EUROPE: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 76

TABLE 79 WESTERN EUROPE: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 77

TABLE 80 WESTERN EUROPE: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 77

TABLE 81 WESTERN EUROPE: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 77

TABLE 82 WESTERN EUROPE: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 78

TABLE 83 GERMANY: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 78

TABLE 84 GERMANY: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 78

TABLE 85 GERMANY: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 79

TABLE 86 GERMANY: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 79

TABLE 87 GERMANY: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 79

TABLE 88 GERMANY: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 80

TABLE 89 GERMANY: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 80

TABLE 90 GERMANY: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 80

TABLE 91 UK: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 81

TABLE 92 UK: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 81

TABLE 93 UK: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 81

TABLE 94 UK: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 82

TABLE 95 UK: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 82

TABLE 96 UK: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 82

TABLE 97 UK: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 83

TABLE 98 UK: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 83

TABLE 99 FRANCE: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 83

TABLE 100 FRANCE: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 84

TABLE 101 FRANCE: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 84

TABLE 102 FRANCE: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 84

TABLE 103 FRANCE: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 84

TABLE 104 FRANCE: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 85

TABLE 105 FRANCE: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 85

TABLE 106 FRANCE: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 85

TABLE 107 ITALY: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 86

TABLE 108 ITALY: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 86

TABLE 109 ITALY: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 86

TABLE 110 ITALY: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 87

TABLE 111 ITALY: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 87

TABLE 112 ITALY: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 87

TABLE 113 ITALY: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 88

TABLE 114 ITALY: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 88

TABLE 115 SPAIN: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 88

TABLE 116 SPAIN: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 89

TABLE 117 SPAIN: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 89

TABLE 118 SPAIN: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 89

TABLE 119 SPAIN: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 89

TABLE 120 SPAIN: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 90

TABLE 121 SPAIN: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 90

TABLE 122 SPAIN: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 90

TABLE 123 REST OF WESTERN EUROPE: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 91

TABLE 124 REST OF WESTERN EUROPE: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 91

TABLE 125 REST OF WESTERN EUROPE: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 91

TABLE 126 REST OF WESTERN EUROPE: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 92

TABLE 127 REST OF WESTERN EUROPE: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 92

TABLE 128 REST OF WESTERN EUROPE: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027

(USD MILLION) 92

TABLE 129 REST OF WESTERN EUROPE: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027

(USD MILLION) 93

TABLE 130 REST OF WESTERN EUROPE: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 93

TABLE 131 EASTERN EUROPE: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 93

TABLE 132 EASTERN EUROPE: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 94

TABLE 133 EASTERN EUROPE: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 94

TABLE 134 EASTERN EUROPE: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 94

TABLE 135 EASTERN EUROPE: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 95

TABLE 136 EASTERN EUROPE: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 95

TABLE 137 EASTERN EUROPE: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 95

TABLE 138 EASTERN EUROPE: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 96

TABLE 139 ASIA-PACIFIC: GENE PANEL MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 97

TABLE 140 ASIA-PACIFIC: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 98

TABLE 141 ASIA-PACIFIC: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 98

TABLE 142 ASIA-PACIFIC: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 98

TABLE 143 ASIA-PACIFIC: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 98

TABLE 144 ASIA-PACIFIC: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 99

TABLE 145 ASIA-PACIFIC: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 99

TABLE 146 ASIA-PACIFIC: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 99

TABLE 147 ASIA-PACIFIC: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 100

TABLE 148 JAPAN: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 100

TABLE 149 JAPAN: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 100

TABLE 150 JAPAN: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 101

TABLE 151 JAPAN: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 101

TABLE 152 JAPAN: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 101

TABLE 153 JAPAN: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 102

TABLE 154 JAPAN: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 102

TABLE 155 JAPAN: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 102

TABLE 156 CHINA: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 103

TABLE 157 CHINA: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 103

TABLE 158 CHINA: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 103

TABLE 159 CHINA: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 104

TABLE 160 CHINA: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 104

TABLE 161 CHINA: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 104

TABLE 162 CHINA: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 105

TABLE 163 CHINA: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 105

TABLE 164 INDIA: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 105

TABLE 165 INDIA: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 106

TABLE 166 INDIA: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 106

TABLE 167 INDIA: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 106

TABLE 168 INDIA: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 107

TABLE 169 INDIA: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 107

TABLE 170 INDIA: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 107

TABLE 171 INDIA: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 108

TABLE 172 AUSTRALIA: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 108

TABLE 173 AUSTRALIA: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 108

TABLE 174 AUSTRALIA: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 109

TABLE 175 AUSTRALIA: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 109

TABLE 176 AUSTRALIA: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 109

TABLE 177 AUSTRALIA: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 110

TABLE 178 AUSTRALIA: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 110

TABLE 179 AUSTRALIA: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 110

TABLE 180 SOUTH KOREA: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 111

TABLE 181 SOUTH KOREA: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 111

TABLE 182 SOUTH KOREA: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 111

TABLE 183 SOUTH KOREA: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 112

TABLE 184 SOUTH KOREA: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 112

TABLE 185 SOUTH KOREA: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 112

TABLE 186 SOUTH KOREA: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 113

TABLE 187 SOUTH KOREA: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 113

TABLE 188 REST OF ASIA-PACIFIC: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 113

TABLE 189 REST OF ASIA-PACIFIC: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 114

TABLE 190 REST OF ASIA-PACIFIC: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 114

TABLE 191 REST OF ASIA-PACIFIC: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 114

TABLE 192 REST OF ASIA-PACIFIC: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 115

TABLE 193 REST OF ASIA-PACIFIC: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027

(USD MILLION) 115

TABLE 194 REST OF ASIA-PACIFIC: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 115

TABLE 195 REST OF ASIA-PACIFIC: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 116

TABLE 196 MIDDLE EAST & AFRICA: GENE PANEL MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 117

TABLE 197 MIDDLE EAST & AFRICA: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 117

TABLE 198 MIDDLE EAST & AFRICA: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 118

TABLE 199 MIDDLE EAST & AFRICA: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 118

TABLE 200 MIDDLE EAST & AFRICA: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 118

TABLE 201 MIDDLE EAST & AFRICA: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 119

TABLE 202 MIDDLE EAST & AFRICA: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027

(USD MILLION) 119

TABLE 203 MIDDLE EAST & AFRICA: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 119

TABLE 204 MIDDLE EAST & AFRICA: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 120

TABLE 205 UNITED ARAB EMIRATES: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 120

TABLE 206 UNITED ARAB EMIRATES: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 120

TABLE 207 UNITED ARAB EMIRATES: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 121

TABLE 208 UNITED ARAB EMIRATES: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 121

TABLE 209 UNITED ARAB EMIRATES: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 121

TABLE 210 UNITED ARAB EMIRATES: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027

(USD MILLION) 122

TABLE 211 UNITED ARAB EMIRATES: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 122

TABLE 212 UNITED ARAB EMIRATES: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 122

TABLE 213 SAUDI ARABIA: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 123

TABLE 214 SAUDI ARABIA: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 123

TABLE 215 SAUDI ARABIA: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 123

TABLE 216 SAUDI ARABIA: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 124

TABLE 217 SAUDI ARABIA: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 124

TABLE 218 SAUDI ARABIA: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027 (USD MILLION) 124

TABLE 219 SAUDI ARABIA: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027 (USD MILLION) 125

TABLE 220 SAUDI ARABIA: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 125

TABLE 221 REST OF MIDDLE EAST & AFRICA: GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 125

TABLE 222 REST OF MIDDLE EAST & AFRICA: GENE PANEL MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION) 126

TABLE 223 REST OF MIDDLE EAST & AFRICA: GENE PANEL MARKET, BY DESIGN, 2020-2027 (USD MILLION) 126

TABLE 224 REST OF MIDDLE EAST & AFRICA: GENE PANEL MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 126

TABLE 225 REST OF MIDDLE EAST & AFRICA: GENE PANEL MARKET, FOR CANCER RISK ASSESSMENT, BY TYPE, 2020-2027 (USD MILLION) 127

TABLE 226 REST OF MIDDLE EAST & AFRICA: GENE PANEL MARKET, FOR COMPREHENSIVE CANCER RISK PANELS, BY TYPE, 2020-2027

(USD MILLION) 127

TABLE 227 REST OF MIDDLE EAST & AFRICA: GENE PANEL MARKET, FOR SYNDROME-SPECIFIC GENE PANELS, BY TYPE, 2020-2027

(USD MILLION) 127

TABLE 228 REST OF MIDDLE EAST & AFRICA: GENE PANEL MARKET, BY END USER, 2020-2027 (USD MILLION) 128

TABLE 229 TOP MANUFACTURERS IN THE GLOBAL GENE PANEL MARKET 129

TABLE 230 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED 132

TABLE 231 AGILENT TECHNOLOGIES, INC.: KEY DEVELOPMENTS 133

TABLE 232 THERMO FISHER SCIENTIFIC: PRODUCTS/SERVICES OFFERED 135

TABLE 233 THERMO FISHER SCIENTIFIC: KEY DEVELOPMENTS 135

TABLE 234 F. HOFFMANN-LA ROCHE LTD: PRODUCTS/SERVICES OFFERED 138

TABLE 235 F. HOFFMANN-LA ROCHE LTD: KEY DEVELOPMENTS 138

TABLE 236 QIAGEN: PRODUCTS/SERVICES OFFERED 141

TABLE 237 QIAGEN: KEY DEVELOPMENTS 141

TABLE 238 ILLUMINA INC.: PRODUCTS/SERVICES OFFERED 144

TABLE 239 ILLUMINA INC.: KEY DEVELOPMENTS 144

TABLE 240 BGI: PRODUCTS OFFERED 147

TABLE 241 BGI: KEY DEVELOPMENTS 147

TABLE 242 INTEGRATED DNA TECHNOLOGIES, INC.: PRODUCTS OFFERED 150

TABLE 243 INTEGRATED DNA TECHNOLOGIES, INC.: KEY DEVELOPMENTS 151

TABLE 244 GENEWIZ: PRODUCTS OFFERED 153

TABLE 245 GENEWIZ: KEY DEVELOPMENTS 154

TABLE 246 NOVOGENE CORPORATION: PRODUCTS OFFERED 155

TABLE 247 NOVOGENE CORPORATION: KEY DEVELOPMENTS 155

TABLE 248 PERSONALIS, INC.: PRODUCTS/SERVICES OFFERED 160

TABLE 249 GATC BIOTECH AG: PRODUCTS/SERVICES OFFERED 164

TABLE 250 ARCHERDX INC: PRODUCTS/SERVICES OFFERED 166

TABLE 251 ARCHERDX INC: KEY DEVELOPMENTS 166

TABLE 252 GENEDX: PRODUCTS/SERVICES OFFERED 168

TABLE 253 CENTOGENE AG: PRODUCTS/SERVICES OFFERED 173

16 LIST OF FIGURES

FIGURE 1 GLOBAL GENE PANEL MARKET: MARKET STRUCTURE 21

FIGURE 2 BREAKDOWN OF PRIMARY RESPONDENTS 25

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 27

FIGURE 4 MARKET DYNAMICS: ANALYSIS OF GLOBAL GENE PANEL MARKET 29

FIGURE 5 DRIVER IMPACT ANALYSIS 31

FIGURE 6 RESTRAINT IMPACT ANALYSIS 32

FIGURE 7 PORTER’S FIVE FORCES ANALYSIS: GLOBAL GENE PANEL MARKET 34

FIGURE 8 VALUE CHAIN ANALYSIS OF THE GLOBAL GENE PANEL MARKET 36

FIGURE 9 GLOBAL GENE PANEL MARKET, BY PRODUCT & SERVICE, 2020 (%) 39

FIGURE 10 GLOBAL GENE PANEL MARKET, BY PRODUCT & SERVICE, 2023-2032 (USD MILLION) 39

FIGURE 11 GLOBAL GENE PANEL MARKET, BY TECHNIQUE, 2020 (%) 42

FIGURE 12 GLOBAL GENE PANEL MARKET, BY TECHNIQUE, 2023-2032 (USD MILLION) 42

FIGURE 13 GLOBAL GENE PANEL MARKET, BY DESIGN, 2020 (%) 45

FIGURE 14 GLOBAL GENE PANEL MARKET, BY DESIGN, 2023-2032 (USD MILLION) 45

FIGURE 15 GLOBAL GENE PANEL MARKET, BY APPLICATION, 2020 (%) 48

FIGURE 16 GLOBAL GENE PANEL MARKET, BY APPLICATION, 2023-2032 (USD MILLION) 48

FIGURE 17 GLOBAL GENE PANEL MARKET, BY END USER, 2020 (%) 52

FIGURE 18 GLOBAL GENE PANEL MARKET, BY END USER, 2023-2032 (USD MILLION) 52

FIGURE 19 GLOBAL GENE PANEL MARKET, BY REGION, 2020(%) 55

FIGURE 20 GLOBAL GENE PANEL MARKET, BY REGION, 2023-2032 (USD MILLION) 55

FIGURE 21 AMERICAS: GENE PANEL MARKET, BY REGION, 2020 (%) 57

FIGURE 22 NORTH AMERICA: GENE PANEL MARKET, BY COUNTRY, 2020 (%) 60

FIGURE 23 EUROPE: GENE PANEL MARKET, BY REGION, 2020 (%) 72

FIGURE 24 WESTERN EUROPE: GENE PANEL MARKET, BY COUNTRY, 2020 (%) 75

FIGURE 25 ASIA-PACIFIC: GENE PANEL MARKET, BY COUNTRY, 2020 (%) 97

FIGURE 26 MIDDLE EAST & AFRICA: GENE PANEL MARKET, BY COUNTRY, 2020 (%) 117

FIGURE 27 GENE PANEL MARKET, COMPETITIVE LANDSCAPE (% SHARE) 130

FIGURE 28 AGILENT TECHNOLOGIES, INC.: FINANCIAL OVERVIEW SNAPSHOT 132

FIGURE 29 AGILENT TECHNOLOGIES, INC.: SWOT ANALYSIS 133

FIGURE 30 THERMO FISHER SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT 134

FIGURE 31 THERMO FISHER SCIENTIFIC: SWOT ANALYSIS 136

FIGURE 32 F. HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT 137

FIGURE 33 F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS 138

FIGURE 34 QIAGEN: FINANCIAL OVERVIEW SNAPSHOT 140

FIGURE 35 QIAGEN: SWOT ANALYSIS 142

FIGURE 36 ILLUMINA INC.: FINANCIAL OVERVIEW SNAPSHOT 143

FIGURE 37 ILLUMINA INC.: SWOT ANALYSIS 145

FIGURE 38 BGI: FINANCIAL OVERVIEW SNAPSHOT 146

FIGURE 39 BGI: SWOT ANALYSIS 147

FIGURE 40 INTEGRATED DNA TECHNOLOGIES, INC.: FINANCIAL OVERVIEW SNAPSHOT 150

FIGURE 41 INTEGRATED DNA TECHNOLOGIES, INC.: SWOT ANALYSIS 151

FIGURE 42 FINANCIAL OVERVIEW GENEWIZ 153

FIGURE 43 GENEWIZ: SWOT ANALYSIS 154

FIGURE 44 NOVOGENE CORPORATION: SWOT ANALYSIS 156

FIGURE 45 FINANCIAL OVERVIEW PERSONALIS, INC. 158

FIGURE 46 PERSONALIS, INC.: SWOT ANALYSIS 160

FIGURE 47 FINANCIAL OVERVIEW GATC BIOTECH AG 161

FIGURE 48 GATC BIOTECH AG: SWOT ANALYSIS 164

FIGURE 49 ARCHERDX INC: SWOT ANALYSIS 167

FIGURE 50 GENEDX: SWOT ANALYSIS 169

FIGURE 51 CENTOGENE AG FINANCIAL OVERVIEW 171

FIGURE 52 CENTOGENE AG: SWOT ANALYSIS 173